Thank you for visiting our taskforce page. Here you will find information about our collaborative approach to develop solutions that support our vision of enhancing life by ensuring appropriate and personalized use of medication and gene therapies.
We have established three taskforces to focus on distinct aspects of getting the medications right™: The Pharmacogenomics (PGx) Payment and Policy Taskforce, the Employer Advisory Taskforce the Building Vaccine Confidence in the Medical Neighborhood National Task Force and the Physician Advisory Taskforce. Each taskforce has a charge or a framework against which it will develop a set of recommendations and/or a tool that will be useful in advancing the mission of each taskforce.
Taskforce Leadership and Membership
While the Employer Advisory Taskforce, the Physician Advisory Taskforce and the Vaccine Confidence Task Force are by invitation only, the PGx Payment and Policy Taskforce is led by representatives from the board of directors and executive member organizations. Incoming board member and executive member organization employees can help lead a taskforce and join colleagues in establishing the strategic priorities for that group while offering sponsorship support as needed.
Signing members of the Institute who are passionate about PGx payment and policy issues and who are willing to contribute their time and expertise are encouraged to volunteer to be part of a taskforce. If you’re not already a signing member, there is no cost to join. To learn more about joining the Institute as a signing member, please visit our membership page.
To learn more about each taskforce, please click on the links below. If you have questions and would like to talk with someone at the Institute about the taskforce, please contact us at firstname.lastname@example.org.
PGx Payment & Policy Taskforce
This group will explore strategies to accelerate delivery reform at the point of care which will enable medication optimization. The taskforce is assembled to find the policy and payment barriers related to adoption of pharmacogenomics (PGx) testing to inform optimized medication use. The purpose of the taskforce is to develop GTMRx guidelines, position statements and draft model legislation as deemed necessary to advance PGx testing and utilization in practice.
Employer Toolkit Taskforce
This group will develop, distribute and build continuous improvement of an employer toolkit to educate employers from “what’s in it for us” to how to be an advocator, leader and implementer of programs designed to optimize medication use through comprehensive medication management (and PGx) in practice. As the largest payer for prescription drugs, employers have much to gain in employee productivity and avoidance of wasted benefit dollars if there is a process of care used to ensure safe, effective and appropriate use of medications.
Vaccine Confidence Task Force
This task force is an invitation-only group of national experts, convened to offer guidance and recommendations to inform the national dialogue around building vaccine confidence for the COVID-19 vaccine (and other vaccines) in the health neighborhood today and in the future. This work is sponsored by Johnson & Johnson.